Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million from investors.… Read More Cardiac Dimensions, a medical device company based ...
KIRKLAND, WA-- Cardiac Dimensions®, Inc. today announced that an update to its landmark TITAN clinical trial will be given as part of the 23rd annual Transcathether Cardiovascular Therapeutics (TCT) ...
KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Dimensions ®, a leader in minimally invasive treatments for heart failure and functional mitral regurgitation (FMR), today announced the close of an ...
Funds Expected to Support Enrollment in U.S. Pivotal EMPOWER Trial and European Commercial Expansion for Carillon Mitral Contour System® KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Dimensions®, a leader ...
Cardiac Dimensions, a medical device company based in Kirkland, Wash., landed $35 million to support testing and marketing of its system to treat mitral valve regurgitation. Mitral valve regurgitation ...
Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s mitral valve repair device. The round was led by investment management firm ...
KIRKLAND, Wash.-- Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results